1,294,589 Shares in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Bought by Voloridge Investment Management LLC

Voloridge Investment Management LLC bought a new position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 1,294,589 shares of the medical instruments supplier's stock, valued at approximately $24,571,000. Voloridge Investment Management LLC owned approximately 0.65% of DENTSPLY SIRONA as of its most recent filing with the SEC.

Several other institutional investors have also recently made changes to their positions in XRAY. Barclays PLC raised its position in shares of DENTSPLY SIRONA by 21.8% in the 3rd quarter. Barclays PLC now owns 306,809 shares of the medical instruments supplier's stock worth $8,301,000 after acquiring an additional 54,920 shares in the last quarter. UMB Bank n.a. raised its position in shares of DENTSPLY SIRONA by 60.8% in the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock worth $28,000 after acquiring an additional 564 shares in the last quarter. MassMutual Private Wealth & Trust FSB raised its position in shares of DENTSPLY SIRONA by 648.4% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier's stock worth $27,000 after acquiring an additional 1,232 shares in the last quarter. Nisa Investment Advisors LLC raised its position in shares of DENTSPLY SIRONA by 89.6% in the 4th quarter. Nisa Investment Advisors LLC now owns 54,397 shares of the medical instruments supplier's stock worth $1,041,000 after acquiring an additional 25,705 shares in the last quarter. Finally, Avior Wealth Management LLC raised its position in shares of DENTSPLY SIRONA by 21.1% in the 4th quarter. Avior Wealth Management LLC now owns 34,400 shares of the medical instruments supplier's stock worth $653,000 after acquiring an additional 6,000 shares in the last quarter. Institutional investors own 95.70% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on XRAY shares. Wells Fargo & Company decreased their target price on DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating for the company in a research report on Friday, February 28th. Barrington Research increased their target price on DENTSPLY SIRONA from $20.00 to $21.00 and gave the stock an "outperform" rating in a research report on Monday, May 12th. UBS Group decreased their target price on DENTSPLY SIRONA from $27.00 to $25.00 and set a "buy" rating for the company in a research report on Friday, May 9th. Needham & Company LLC restated a "hold" rating on shares of DENTSPLY SIRONA in a research note on Thursday, March 13th. Finally, Morgan Stanley downgraded DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 price target on the stock. in a research note on Tuesday, April 15th. Eleven analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to data from MarketBeat.com, DENTSPLY SIRONA presently has an average rating of "Hold" and a consensus target price of $20.36.

Insider Buying and Selling at DENTSPLY SIRONA

In other news, Director Gregory T. Lucier purchased 15,142 shares of the company's stock in a transaction dated Monday, March 3rd. The shares were purchased at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the purchase, the director now directly owns 81,971 shares in the company, valued at approximately $1,353,341.21. This represents a 22.66% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Company insiders own 0.52% of the company's stock.

DENTSPLY SIRONA Stock Down 2.4%

XRAY traded down $0.38 during trading on Friday, hitting $15.47. 2,475,144 shares of the company's stock traded hands, compared to its average volume of 2,968,748. The company's 50 day simple moving average is $14.47 and its two-hundred day simple moving average is $17.08. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA Inc. has a 12-month low of $12.16 and a 12-month high of $28.25. The stock has a market capitalization of $3.08 billion, a price-to-earnings ratio of -7.47, a PEG ratio of 1.80 and a beta of 0.92.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 EPS for the quarter, beating the consensus estimate of $0.29 by $0.14. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The business had revenue of $879.00 million for the quarter, compared to the consensus estimate of $854.75 million. During the same period last year, the business posted $0.42 EPS. The company's revenue was down 7.8% compared to the same quarter last year. Analysts predict that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were paid a dividend of $0.16 per share. The ex-dividend date was Friday, March 28th. This represents a $0.64 annualized dividend and a yield of 4.14%. DENTSPLY SIRONA's dividend payout ratio is -14.10%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.